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1 Introduction 
 
1.1 Adult neurogenesis 
 
In the last few decades adult neurogenesis has moved into the focus of 
neurobiological research [1] [2]. New neurons are generated throughout life, but 
the degree of postnatal neurogenesis decreases with increasing brain 
complexity. In lower vertebrates neurogenesis provides an additional supply of 
neurons capable of regenerating entire brain parts, whereas in mammalians 
adult neurogenesis is restricted to only a few regions of the brain [3]. The 
newborn neuronal cells originate from adult neural stem cells in the germinal 
zones, which are defined by their ability to self-replicate and differentiate into all 
types of neural lineages [4]. The neuronal tissue is composed of neurons, 
neuroglia and ependymal cells. Neurons are the functional components of the 
nervous system and are responsible for information processing and 
transmission. They may be defined in terms of their structure and in 
consequence can be distinguished from neuroglia by their specialized polarized 
processes, the axons and dendrites, which may propagate action potentials and 
make synaptic junctions with other neurons and cells [5]. Microglia are resident 
macrophages/monocytes of the central nervous system (CNS); they represent 
the first defense line of the brain in case of infects, secrete cytokines, reactive 
oxygen radicals, and proteases, and are able to phagocytose bacteria or cell 
debris. They have also important roles in the brain by removing surplus neurons 
and stripping synapses during development. Astrocytes and oligodendrocytes, 
collectively known as macroglia, play supporting roles that are essential for the 
proper functioning of the nervous system. Oligodendrocytes are myeling-
forming cells that allow the rapid conduction of neuronal impulses along axons, 
while astrocytes provide important structural, metabolic and trophic support to 
neurons [6]. Ependymal cells are the support cells that line the ventricular 
cavity. In mammals, the adult neurogenesis is limited to only two specific 
niches, the subventricular zone (SVZ) of the lateral ventricles and the 
subgranular zone (SGZ) of the dentate gyrus (DG) in the hippocampus [7] [2]. In 
these germinal zones new neurons are continuously added to existing neural 
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circuits. These cells are definitely functional and may play an important role in 
hippocampal learning and memory functions [8].  
 
1.1.2 Subgranular zone neurogenesis 
 
1.1.2.1 The structure and function of the hippocampus 
 
The hippocampus is a part of the limbic system that plays an important 
role in learning, memory and long-time potentiation [9]. The hippocampus 
formation is found in the medial temporal lobe and is consisting of the dentate 
gyrus (DG), hippocampus (CA1;CA2;CA3), subiculum, presubiculum, 
parasubiculum, and the enterohinal cortex. These areas are largely connected 
by unidirectional inputs, including a projection from the entohinal cortex (EC) to 
the DG (perforant path; (PP)), the mossy fiber (MF) input that links the DG with 
the CA3, and the CA3 area projecting to the CA1 region via the Schafer 
collaterals (SC) [10] (Figure 1).  
 
 
The dentate gyrus, where the neurogenesis occurs, consists of three 
layers. The molecular layer is relatively cell-free layer which, is occupied by the 
dendrites of the granule neurons, the fibres of the perforant path and also a 
Figure 1. Schematic diagram of the hippocampal formation illustrating 
principal areas and the main projections [127] 
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small number of interneurons. The principal layer is the granule cell layer which, 
is made up largely of densely packed granule cells. This layer encloses the third 
layer, the polymorphic cell layer, where a number of different cells are located 
[11]. The dentate gyrus is ideally situated to act as a “gate”, limiting the amount 
of the excitatory input entering the hippocampus [12]. 
 
1.1.2.2 The mechanism of subgranular neurogenesis 
 
Granule neurons in the DG are continually born locally in the subgranular 
zone, which lies between the granule cell layer and the hilus. Two types of 
neural progenitors can be identified according to their specific morphologies and 
expression of molecular markers. Type 1 cells, also called radial glial cells, have 
triangular soma, a radial process spanning the entire granule cell layer and 
ramify in the inner molecular layer [13]. These cells show neuroepithelial and 
astroglial properties at the same time [14]. Radial glial cells express the 
intermediate filament protein nestin, which is expressed in the early stages of 
development and participate in the remodeling of the cell [15]. They also 
express glial fibrillary acidic protein (GFAP), a typical marker of astrocytes [16] 
and Sox2, a transcription factor [17]. The electron microscopic examination after 
3[H]-thymidine injection showed, in addition two groups of dividing cells. Type 1 
cells which have light cytoplasm containing few ribosomes, intermediate 
filaments, and irregular contours [18]. They represent more fate-restricted 
progenitors than neuroepithelial cells, but they divide asymmetrically, so they 
give rise on the one hand to neural progenitor cells (NPCs) and on the other 
hand to either astrocytes, oligondendrocytes or neurons [19]. Type 2 cells have 
a shorter horizontal shape, they lack processes and have a round or ovoid 
soma [20]. These cells still express nestin, but they do not express GFAP and 
they are highly proliferative. The electron microscopic analyses showed 
smoother contours, dark scant cytoplasm with many ribosomes and darker 
nuclei [18]. Type 2 cells come in two subtypes (type 2a and 2b), one negative 
and one positive for immature neuronal marker doublecortin (DCX) [21]. 
Presumably, at this stage a fate choice decision toward neuronal development 
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is possible, the developing cells express Prox-1 as the earliest persistent 
marker of future granule cells [22]. However, at this stage the cells can still 
divide. Based on these properties, we can consider type 1 cells as stem cells, 
type 2 cells as transiently amplifying, lineage-determined progenitor cells, and 
type 3 cells as neuroblasts [23] (Figure 2). Type 3 cells are DCX-positive, they 
all express the cell adhesion molecule PSA-NCAM, as some type 2 cells [24], 
and they do not express nestin anymore. Neuroblasts are also proliferative, the 
nucleus of the cells is rounded. In the SGZ neuroblasts migrate a short 
distance. First they form clusters adjacent to the inner margin of the granular 
cell layer; these cells are without processes. During migration they send out 
short processes oriented parallel to the granule cell layer, migrate deeper in this 
layer and develop further into granule neurons [21]. 
 
At the next stage, the maturing granule cells become postmitotic. The 
DCX expression persists onto this stage. The majority of cells reach this stage 
after 3 days. A surplus of immature neuronal cells provides a pool of neurogenic 
potential from which appropriate functional stimuli can recruit more new neurons 
[25] [26]. Within 4 more days the number of cells drops dramatically and a few 
Figure 2. The clearly differentiable developmental stages of the adult 
neurogenesis in the hippocampus. Neurons originate from the astrocytic radial glia 
cells (1), which develop through the transiently amplifying progenitors (2;3) and 
neuroblasts (3) to become a granule neuron (5:6). The most important 
morphological properties and  the markers expressed throughout development are 
shown [23].  
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weeks after the initial division reaches a level that remains stable over months 
and years [27]. The early postmitotic stage is characterized by the transient 
expression of Ca2+-binding protein calretinin. This expression peaks between 3 
days and 1 week after division and it is generally required for the maturation of 
certain neuronal properties [28]. Maturing granule cells switch their calcium-
binding protein from calretinin to calbindin, which occurs very swiftly. This time 
point is very important in the development, because granule cells need 
calbindin to control calcium homeostasis and to regulate calcium channel 
activity [29]. Some of the cells switch the expression form DCX to the more 
mature marker NeuN. Even 1 day after BrdU-injection (a typical marker of 
dividing cells), one can find cells labeled for both BrdU and NeuN [30]. Another 
important marker, Prox1 is also expressed in all postmitotic cells [31]. Axons of 
adult-generated cells were found in the CA3 area between 4 and 10 days after 
BrdU labeling. At this time they have not yet attained mature morphologic or 
biochemical characteristics of granule cells. At later time points (4-7 weeks) 
most of the labeled cells were indistinguishable from mature cells [32] [33].  
 
1.1.2.3 Regulation of adult hippocampal proliferation 
 
The adult hippocampal neurogenesis is influenced at multiple levels. One 
of the most studied fields is the influence of the neuronal activity from the 
surrounding hippocampal circuitry. Neural progenitor cells first receive 
GABAergic input from the perforant pathway. Although many types of axons, 
including glutamategic and cholinergic systems, penetrate into the SGZ, only 
GABAergic terminals make functional contact with the progenitor cells [34]. 
First, GABA acts as an excitatory transmitter because of the elevated 
intracellular chloride level, a phenomenon described in embryonic neuronal 
progenitor cells [35]. GABA-mediated synaptic activity can trigger action 
potentials and increases in cytoplasmatic Ca2+ due to the opening of voltage-
gated Ca2+-channels [36]. This is mediated by GABAA-receptors, which are 
present on the hippocampal type 2 progenitor cells [37]. The GABA application 
also increases the expression of NeuroD, a transcription factor that is required 
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for neuronal phenotype generation [38]. GABAergic interactions are the source 
and target of the first neural contacts formed in the hippocampal neuro-germinal 
zone. The effect of GABA on proliferation is time-dependent and acts in 
opposing directions: once directly on the progenitors and once by the 
intervention of the hippocampal neuronal activity. Within a few days after 
agonist application (phenobarbital/pentobarbital) decreased neurogenesis can 
be observed, but after one month, the number of calbindin-positive cells is 
elevated [34]. The presence of other receptors and the influence of other 
mechanisms in the neurogenesis is controversial. Some groups found functional 
glutamate receptors on type 2 progenitors [36] [39] [40], while others observed 
no effect of glutamate agonists on neural stem cells [34]. The NMDA receptors 
become functional at later stages of development compared to AMPA/kainat 
(KA) receptors and exhibit Ca2+ responses and depolarizing currents only when 
the cells have differentiated into young postmitotic neurons, around the time 
when neuronal migration starts [41]. Glutamate receptors may regulate the 
number of NPCs within the neurogenic zones and the adult brain as well as the 
number of newborn cells according to physiological needs by either suppressing 
or promoting basal and injury-induced neurogenesis. Glutamate acting on 
glutamate receptors may also regulate the expression of growth factors or 
neurotrophic factors involved in mediating neurogenesis [40]. The effects of 
GABA and glutamate on stem cells are the most studied regulators of 
neurogenesis, but there are other important ways of impact, such the activation 
of noradrenergic 2- and  receptors [42], dopaminergic D1-receptors [43], and 
cholinergic stimuli [44]. 
 
1.1.2.4 Functional significance of adult hippocampal neurogenesis 
 
The common perception is that new neurons in the adult brain would be 
beneficial, but there must be a trade-off between the benefits accrued from new 
neurons and the problems they cause for the network structure into which they 
need to integrate. In order to understand this fully, we need a much broader 
definition, one that incorporates psychology and surpasses the three different 
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levels (cellular, network, system), where adult neurogenesis can be considered. 
Manipulation of adult neurogenesis and of a potential functional outcome occur 
on different time scales, making it likely that the function of new neurons is part 
of long-term adaption processes rather than of acute benefits [45]. If newly 
generated granule cells were functionally similar, they could replace older 
granule cells as they senesce and transient changes in neurogenesis might 
exert only minimal effects on hippocampal function. Conversely, physiological 
studies clearly demonstrate that newborn granule cells exhibit a number of 
distinctive properties, including greater plasticity, enhanced excitability and 
reduced threshold for long-term potentiation relative to mature granule cells [46] 
[47]. In addition, emerging research implicates dysregulation of granule cell 
neurogenesis in several diseases, including depression and epilepsy.  
Epilepsy is a multifarious and debilitating disease, which is defined 
clinically by the occurrence of two or more unprovoked seizures. Seizures can 
originate from different regions of the brain, one of the most common form is the 
temporal lobe epilepsy with the involvement of the hippocampus [48]. In 
commonly-used status epilepticus models, animals receive a precipitating injury 
to the brain to induce epilepsy and acute cell loss. This injury is followed by a 
phase lasting days to weeks, called “latent period”, in which spontaneous 
seizures are infrequent or absent. Surprisingly, the latent period is associated 
with dramatic increase in granule cell neurogenesis [49], but more likely, 
epilepsy reflects a combination of many changes in the brain (changes is ion 
channels, synaptic properties, inflammation, glial changes, cell loss and 
widespread circuit changes [50]). In the case of status epilepticus three unique 
pathologies of the dentate gyrus are worthy for attention. The first, called mossy 
fiber sprouting, occurs when granule cell axons sprout into the dentate inner 
molecular layer and form excitatory synaptic connections with neighboring 
granule cells [51]. The second form of pathology occurs when granule cells 
migrate to ectopic locations within the dentate hilus [52], they also exhibit higher 
ratios of excitatory to inhibitory inputs than normal granule cells [53]. The third 
pathology arises when granule cells develop basal dendrites projecting into the 
dentate hilus, so they receive significant recurrent input from neighboring 
granule cells [54]. Whereas, epilepsy is associated with increased 
neurogenesis, after several months dramatically reduced neurogenesis can be 
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observed in animals [55]. This can be the connection between the high co-
morbidity of epilepsy and depression [56]. In animal models, stressful stimuli, 
such as sleep deprivation or social isolation reduce granule cell neurogenesis 
[57]. Curiously, reduced granule cell neurogenesis may also impair the dentate 
gate and may lower the threshold for epileptogenesis to occur [58]. 
Subsequently, patients with epilepsy are at increased risk for depression, and 
prior history of depression increases the risk for new-onset epilepsy.  
 
1.1.3. Subventricular zone neurogenesis 
 
The postnatal subventricular zone (SVZ) of the lateral ventricles is the 
largest germinal center in the postnatal mammalian brain, composed of several 
distinct cell types including stem cells and progenitors committed to a neuronal 
or glial lineage [59]. The SVZ is organized around chains of neuroblasts  (Type 
A cells) that course tangentially to the walls of the lateral ventricle, these chains 
are encapsulated and isolated from the parenchyma by GFAP-positive 
astrocytes (Type B cells) [60] (Figure 3).  
 
 
 
 
 
 
 
 
 
Figure 3.  The morphology of the subventricular zone. Stem cells (B) 
give rise to new stem cells or to transit-amplifying cells (C), both cell 
types embrace a population of immature neurons (neuroblasts, A) that 
are designated to migrate towards the olphactory bulb (OB) via the 
rostral migratory stream (RMS) [131] 
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These cells constitute a pool of stem cells [61]. The transit-amplifying cells 
(Type C cells), which are PSA-NCAM- and DCX-positive, are associated with 
the migrating neuroblasts only in the SVZ [60]. After birth in the SVZ, neuroblast 
migrate tangentially to the olfactory bulb (OB) through a distinct pathway called 
the rostral migratory stream (RMS). The RMS contains specialized surrounding 
glial cells, which form tube-like structure, serving as a scaffold for the cells [62]. 
The migratory chains are closely associated with blood vessels [63] [64]. When 
they reach the OB, migrating neuroblasts detach from the chains and migrate 
radially to their final position in the granular cell layer or glomerular layer. The 
vast majority of the cells, about 95% differentiate into granule cells [65]. Five 
different stages of the differentiation have been defined, until they reach the 
structure and feature of mature granule cells [66]. The minority of the cells 
differentiate into periglomerular cells (PG), however, they form all of the 
molecular and morphological subtypes of PG cells identified [67]. The functional 
significance of adult neurogenesis in the olfactory bulb in unclear. Genetic 
ablation of adult-born cells, with resulting decrease in granule cell number, does 
not cause any deficits in olfactory discrimination or acquisition of olfactory 
associated memories, at least in the tested paradigms [68].  
 
1.2 Purinergic signaling 
 
Purinergic transmission, involving release of ATP, plays a key role in 
neurotransmission and neuromodulation, with its effect being mediated by the 
purine and pyrimidine receptor subfamilies, P1 and P2. ATP plays a long-term 
role in cell proliferation, differentiation and death, in development and 
regeneration, as well as in diseases [69] [70]. P1 receptors are a class of G 
protein-coupled receptors with adenosine as endogenous ligand; four subtypes 
can be distinguished in humans [71]. Two major families constitute the P2 
receptors: the ligand-gated ion channel P2X receptor with seven different 
subunits and the G protein-coupled P2Y receptor (eight subunits). P2X 
receptors are responding to ATP only, while P2Y receptors are sensitive to 
pyrimidines as well as purines [72]. After the release of ATP (for example by 
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vesicular release from neurons [73] or astrocytes [74] or release with the 
involvement of ATP-binding cassettes, connexin or pannexin hemichannels, as 
well as P2X7 receptors [75]), the nucleotides undergo rapid enzymatic 
degradation by endonucleotidases, which is functionally important since ATP 
metabolites act as physiological ligands for various purinergic receptors [76]. 
Astrocytes and microglia express many purinergic receptor subtypes, but the 
patterns of expression are complex and can change with physiological and 
developmental conditions [77]. ATP participates in both short-term calcium 
signaling events and long-term proliferation, and also in the differentiation and 
death of glia [78] and the formation of reactive astrocytes [79]. Neurons also 
possess both classes of P2 receptors: P2X mediates fast synaptic currents, 
whereas P2Y mediates slow changes of the membrane potential [80]. Purinerg 
signaling is emerging as a major means of integrating functional activity 
between neurons, glial and vascular cells in the CNS. These interactions 
mediate effects on neuronal activity, and are involved in development and or 
are associated with neurodegeneration, myelination, inflammation and cancer 
[81] [82].   
 
1.2.1 P2X7 nucleotide receptor 
 
P2X receptors form a family of at least seven subunits. The subunits 
have two transmembrane domains, a large extracellular loop containing the 
ATP binding site, as well as intracellular N and C terminal tails [83]. Biochemical 
evidence indicates that the receptors occur as stable trimmers of three or six 
subunits, moreover, heteromultimeric assemblies have been described, while 
P2X7 does not co-assemble with any other subunits [84]. P2X receptors can be 
classified into rapidly (P2X1; P2X3) and slowly desensitizing types (P2X2; 
P2X5; P2X6; P2X7) [85].  
The P2X7 subunit is 595 amino acid long, having 35-40% homology with 
the other six members of the P2X family [86]. Although its structure is basically 
similar to the residual P2X receptor subunits, the P2X7 receptor has a unique 
structural feature, its intracellular carboxy terminal is much longer than those of 
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other P2X subunits (Hiba! A hivatkozási forrás nem található.). The activation of 
he P2X7 receptor-gated ion channels leads to two distinct responses, 
depending on the exposure time of agonist. Following a brief application, a non-
selective inward cationic current can be recorded, while upon repeated or 
prolonged application the opening of a membrane pore can be detected, which 
renders the membrane permeable to high molecular weight molecules and ions 
up to the size of 800 Da [86].  
 
 
 
 
 
 
 
 
 
The pore formation is characterized by the uptake of high molecular 
weight fluorescent dyes, such as Lucifer yellow, and is followed by cytoskeletal 
rearrangement such as membrane blebbing, which eventually leads to cell 
death in immune cells [87]. The long intracellular C-terminal domain has been 
shown to be instrumental for the pore-forming property of the receptor [88]. It is 
also clear, that unlike other P2X receptor subunits, the P2X7 receptor does not 
hetero-oligomerize and functions most likely as a homo-trimer, in macrophages 
in the periphery as a hexamer, or is expressed as a monomer in the resting 
microglia in the brain [89].  
The P2X7 receptor is widely expressed in the central nervous system, 
such as the cortex, hippocampus, brainstem, nucleus accumbens and the 
spinal cord [90] [91]. The P2X7 receptor-subtype appears to be limited to 
activated microglia, lymphocytes, macrophages or astroglia, in accordance with 
Figure 4 Illustration of P2X7 receptor with 
extracellular loop, transmembrane domains as well 
as N- and C-terminal tails  
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its role in brain repair following inflammation, infarction or immune insult [92]. 
Recently, however, both P2X7 receptor mRNA and immunoreactivity were 
found to be targeted to presynaptic excitatory but not inhibitory terminals in the 
spinal cord and brain [93].  
The P2X7 receptor has a very low affinity to the endogenous ligand ATP, 
which is crucial in the evaluation of the physiological/pathological role of the 
receptor. ATP is ubiquitous; there is a large pool available for release in the 
CNS. The majority of cellular ATP is formed in the mitochondria of neurons, 
astrocytes, endothelial tissue and microglial cells by oxidative phosphorylation. 
ATP-metabolizing ectoenzymes, such as ectoNTPDases may limit the 
availability of this purine [94]. A multitude of studies indicate, that the activation 
of the P2X7 receptor can alter the pre and/or postsynaptic function of the 
terminals [95]. Since the ATP release from neuronal cells is highly frequency-
dependent, one possibility is that P2X7 receptors serve as molecular sensors of 
increased neuronal activity and contribute to short- or long-term plasticity 
phenomena, such as memory formation [96]. On the other hand, pathological 
events such as mechanical or metabolic stress, inflammation, cellular injury or 
changes in the ionic environment [97] [98] are also known to powerfully 
stimulate ATP release and cause prolonged accumulation of the purine, which 
leads to the upregulation and widespread activation of the receptor [99]. Diverse 
pathological cascades, such as glutamatergic excitotoxicity, oxidative damage, 
cytokine mediated signaling will be activated and under conditions of persistent 
activation, P2X7 receptors might convey a cell death signal, triggering the 
apoptosis or necrosis of cells expressing it [100]. Furthermore, P2X7 receptor 
stimulation elicits or reinforces the release of ATP, thereby providing an auto-
stimulatory loop [101]. Recent data indicate, that that genetic deletion or 
pharmacological blockade of the receptors alter the responsiveness in animal 
models of neurological disorders. Enhanced immunoreactivity of the P2X7 
receptor was found after status epilepticus in microglial cells [102] and neurons 
[103]. The immediate effect of P2X7 receptor antagonists applied together with 
kainic acid to cause status epilepticus, was attenuation of seizures and, in 
consequence, amelioration of the histological damage in neurons and 
astrocytes [104]. The genetic deletion of the receptor resulted in antidepressive-
like behavior in animal models [105]. In conclusion, P2X7 receptor-mediated 
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pathways appear to be a common avenue of many CNS disorders of different 
aetiology, and P2X7 antagonists are potential drugs to treat them.  
 
1.2.2 P2Y nucleotide receptors 
 
The P2Y family comprises of 10 cloned and functionally defined subtypes 
[106]. Eight of them are present in human tissue of which P2Y1, P2Y6, P2Y11, 
P2Y12, P2Y13 and P2Y14 occur in the CNS [107]. The receptor proteins 
contain the typical features of G protein-coupled receptors including seven 
predicted hydrophobic transmembrane regions. The P2Y1, P2Y2, P2Y4, P2Y6 
and P2Y11 are coupling via Gq/11 proteins to stimulate phospholipase C (PLC), 
resulting in hydrolysis of membrane phosphatidylinositol 4,5-bisphosphate to 
generate inositol triphosphate (IP3) and diacylglycerol (DAG), and mobilization 
of intracellular Ca2+ by IP3. P2Y12, P2Y13 and P2Y14 activate Gi proteins to 
inhibit adenylate cyclase, thus reducing intracellular cAMP levels and 
decreasing cellular Ca2+ concentration [108]. These alterations in calcium levels 
modulate the activity of several secondary messengers involved in many 
physiological processes, like cell death, proliferation and stem cell 
differentiation. P2Y1, P2Y12 and P2Y13 receptors react to adenine nucleotides 
only, whereas P2Y6 is a uridine nucleotide-sensitive receptor [109].  P2Y1 
receptors are the most highly expressed and widely distributed receptor subtype 
of the family in the CNS [107].  
 
1.2.3 Purinergic signaling in adult neurogenesis 
 
ATP is considered to be the phylogentically most ancient epigenetic 
factor, exerting short-time actions, as modulating excitability of neurons, and 
long-term trophic effects necessary for embryonic development [110]. Several 
aspects of purinergic system functioning in embryonic development of different 
species and other tissues have been discussed in a recent review [111]. In the 
adult brain, a number of signals direct the proliferation and fate commitment of 
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the transit amplifying cells in the neurogenic niches [112]. Mobilization of mouse 
SVZ NPCs and NSCs is likely to be mediated by ATP [113]. Crucial functions 
have been suggested for the P2Y1 receptor [114]. The purinergic system does 
not only interfere with proliferation and differentiation of NSCs but also with the 
migration of these cells, possibly via P2Y1, P2Y2 and P2Y13 receptor 
activation, an important process to direct newborn neurons to their sites of 
synapse and network formation [115]. Studies conducted in mouse brain slices 
showed not only that SVZ NSCs express functional P2X7 receptors [116], but 
also that ependymal cells located along the lateral ventricle in contact with 
NSCs express the receptor [117]. Since this purinergic receptor subtype 
regulates apoptosis and necrosis of NSCs, it has been suggested that P2X7 
exhibit in SVZ NSCs’ cytotoxic properties [118]. 
 
1.2.4 Aim of the study 
 
Adult NPCs are able to replace damaged neurons, astrocytes and 
oligodendrocytes in the brain. The hippocampus, including the DG, plays an 
important role in memory and other behavioral processes. After epileptic 
seizures enhanced neurogenesis can be detected. This surplus of newly 
generated cells seems not to be beneficial. Such, NPCs migrate to ectopic 
regions and mature to abnormal, hyperexcitable granule cells, which play an 
important role in the evolution of temporal lobe epilepsy [119]. The P2X7 
receptor also known as death receptor, is widely expressed in the CNS [72]. 
Under pathological conditions, poor formation of the P2X7 receptor can be 
observed, which leads to apoptosis or necrosis. Preliminary experiments clarify, 
that SVZ NPCs express functional P2X7 receptors in culture [116]. Because of 
the differences between the two neurogenic niches, we cannot conclude, that 
NPCs in the SGZ express this receptor, as well. P2Y1 receptors are also widely 
expressed in the CNS and play an important role in the migration of the 
neuroblasts [114]. We intend to demonstrate the presence of P2X7 and P2Y1 
receptors at postnatally generated NPCs of the SGZ. We assume, that these 
receptors play an important role in physiological and pathophysiological 
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processes and that the activation of the P2X7 receptor counterbalances the 
overt generation of new, ectopically situated and wired neurons in the hilus 
hippocampi. 
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Suppl. Figure 1 Classif ication of hippocampal neural progenitor cells (NPCs), neuroblasts and granule cells on the 
basis of their voltage-current characteristics in brain slices. Whole-cell recordings from type 1 (A) and type 2 (B) NPCs, 
neuroblasts (B), as w ell as immature (D) and mature granule cells (E) are show n. (a) Hyper- and depolarizing current 
pulses of increasing amplitudes w ere injected into the respective cells at the resting membrane potential (see Methods 
Section). (b) Voltage steps of increasing amplitudes w ere delivered from the holding potential of -80 mV (see Methods 
Section). (c) I/V patterns at the initial transient (f illed circle) and late steadystate (empty circles) current amplitudes of 
the original tracings (c). Recordings from individual cells are documented in each panel. (F) Recording arrangement 
from the subgranular zone of the dentate gyrus (DG) under light microscopic observation. (E) Fluorescent microscopic 
image during recording from the subgranular zone. The w hite arrow  points to the cell w e have recorded from. 
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Suppl. Figure 2 Pharmacological characterization of P2X7 receptors on subventricular zone (SVZ) neuroblasts and 
dentate gyrus subgranular zone (SGZ) neurons. Membrane currents from SVZ neuroblasts w ere recorded by the 
perforated patch method, w hile analogous currents from SGZ neurons w ere recorded by the w hole-cell patch clamp 
method. The holding potential w as -80 mV in both cases. (A) Representative tracings from neuroblasts stimulated by 
Bz-ATP (300 μM; a), in normal or low  X2+ bath medium, respectively. Percentage mean±S.E.M. changes of the current 
amplitudes w hen compared w ith the 2nd current amplitude in a series of applications (b). *P<0.05; statistically 
signif icant difference from 100 % (2nd empty column). (B) Percentage mean±S.E.M. changes by antagonists of the 
current amplitudes in comparison w ith the 2nd current amplitude in a series of applications. The antagonists used w ere 
A438079 (10 μM; a) w ith selectivity for P2X7 receptors, and a cocktail (AP-5; 50 μM; CNQX, 20 μM; gabazine, 10 μM; 
TTX, 0.5 μM) w ith selectivities for NMDA, AMPA and GABAA receptors as w ell as voltage-sensitive Na+ channels (b). 
*P<0.05; statistically signif icant difference from 100 % (empty column). (C) Current response to Bz-ATP (300 μM) and 
superfusion with low X2+ bath medium (10 s each, same pressure) onto a granule neuron. (D) Failure of an antagonist 
cocktail (see Bb) to inhibit the Bz-ATP (300 μM)-induced current amplitudes. (E) Similar failure of A438079 (10 μM) to 
inhibit the Bz-ATP (300 μM)-induced current. Representative tracing from one neuron (a) and percentage mean±S.E.M. 
changes by A438079 of the current amplitudes in comparison w ith the 2nd current amplitude in a series of applications 
(b). The number of cells is indicated in each column. 
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Suppl. Figure 3 Increase of Bz-ATP effect on astrocytes in the subgranular zone of  the dentate gyrus after pilocarpine 
or kainic acid incubation; presence of P2X7 receptors in astrocytes and NPCs. (A) Bz-ATP (300 μM)-induced current 
responses of astrocytes identif ied in the subgranular zone of Tg(nestin/EGFP) mice. Representative recordings of Bz-
ATP currents in brain slices kept for 1 h in aCSF (control), or either pilocarpine (10 μM) or kainic acid (10 μM) (a). The 
percentage changes of the Bz-ATP currents of the indicated number of cells in comparison w ith controls (100%) are 
show n in (b). *P<0.05; statistically signif icant changes. (B) Tw o populations of Bz-ATP-sensitive cells in the subgranular 
zone. Small current responses to Bz-ATP (300 μM; supposed astrocytes) and large current responses to Bz-ATP (300 
μM; supposed NPCs). Representative recordings (a) and mean±S.E.M. of the indicated number of cells (b). *P<0.05; 
statistically signif icant differences from the astrocytic responses. 
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Suppl. Figure 4 Confocal images of multiple immunofluorescence labeling of NPCs located outside the SVZ in the 
hippocampus of a Tg(EGFP/nestin) mouse subjected 24 h before decapitation/slice preparation to pilocarpine (300 
mg/kg, i.p.)-induced status epilepticus. The Hoechst 33342 staining of cell nuclei is color-coded by w hite (e). (A) EGFP-
staining of nestin-positive NPCs (a) and GFAP staining of GFAPpositive astrocytes/Type 1 NPCs (b); P2X7 receptor-
immunoreactivity on NPCs (c; arrow s in a-c). Double staining of EGFP and P2X7 (d, f; f illed head arrow ); triple staining 
of EGFP/GFAP and P2X7 (d; open head arrow ) and a higher magnif ication of the labelled cells (f). (B) Localization of 
the P2Y1 receptor on NPCs (arrows). Triple staining of EGFP/GFAP and P2Y1, in low er (d) and higher magnif ication (f). 
Scale bars for the low er magnif ication panels 20 μm and for the higher ones 15 μm. 
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Suppl. Figure 5 Prevention of the status epilepticus-induced neuronal degeneration in the CA3 and CA3 regions of the 
rat hippocampus by AZ10606120. Status epilepticus w as elicited by pilocarpine (370 mg/kg i.p.); brain slices for 
f luorescence light microscopy w ere prepared 24 h afterw ards and w ere stained w ith Fluoro Jade-B as a marker of 
injured neurons. I.p. saline served as a control, w hen applied instead of pilocarpine. In some of the experiments 
AZ10606120 (1, 2, or 3 μg i.c.v.) w as applied 30 min after i.p. pilocarpine or saline. I.c.v. saline w as injected as a control 
for AZ10606120. The pilocarpine-induced status epilepticus damaged CA1 (A) and CA3 (B) pyramidal cells. Such 
damage w as maximal in rats treated w ith pilocarpine plus saline (a), but w as missing in rats treated w ith saline only (b). 
AZ10606120 prevented the degeneration of CA1 and CA3 cells w hen applied after pilocarpine (c). The scale bars 
indicate 50 μm throughout. 
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Suppl. Figure 6 Blockade of P2X7 receptors increases spontaneous seizures in rats  subjected to a pilocarpine-induced 
status epilepticus. Brilliant Blue G (BBG; 50 mg/kg) injected intraperitoneally (i.p.) to rats did not alter the latency time of 
spontaneous seizures following pilocarpine-induced status epilepticus (A) but increased the number of seizure attacks 
(B) and the number of seizure attacks reaching the indicated intensity on a Racine scale (C). Intracerebroventricularly 
(i.c.v.) injected AZ10606120 (3 μg; replotted from Fig. 6) had an effect comparable to that of BBG. Box plots (median, 
f irst and third quartiles; maximum and minimum 
values) of measurements on 6 rats per group. *P<0.05; statistically signif icant differences from the respective 
“Pilo+saline” groups. 
 
 
 
- 43 - 
 
3 Summary 
 
3.1 Introduction  
 
Adult neurogenesis is one of the intensively investigated topics in the last 
few decades. The fact, that, newly generated cells are able to replace neurons, 
astrocytes and oligodendrocytes, opens the door for new therapeutic methods. 
Due to the importance of these findings, further investigations are required, in 
order to get acquainted with the properties NPCs and their maturation to 
neurons.  
Purinergic signaling plays an important role in many processes of the 
CNS, such as neurotransmission in neuronal-glial communication, mediation of 
neuropathic pain and the evolution of several pathophysiological diseases. 
Preliminary work showed, that SVZ NPCs express the P2X7 receptor and P2Y1 
receptors, which play an important role in the regulation of stem cell proliferation 
and the migration and differentiation of neuroblasts. We aimed at investigating 
whether these receptors are also expressed in the SGZ NPCs and how epileptic 
seizures effect their expression and function. 
 
3.2 Methods 
 
For the experiments we used mice of either sex (10-20 days old) 
overexpressing green fluorescent protein under the control of the nestin 
[Tg(nestin/EGFP)] gene promoter. Coronal hippocampal slices were prepared 
for the patch-clamp recordings. NPCs were visualized by an upright 
fluorescence microscope. After establishing whole-cell access, we could 
differentiate between type 1 and 2 stem cells as well as immature and mature 
granule cells by means of current- and voltage-clamp protocols. By the 
application of different agonists and antagonists, we were able to identify 
functional P2X7 and P2Y1 receptors on NPCs. Neuroblasts were investigated in 
the RMS; for these experiments corticostriatal slices were prepared. Due to the 
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size and the properties of this cell type, the perforated patch clamp method had 
to be used. 
Immunofluorescence labeling was also used to visualize P2X7 and P2Y1 
receptor on the NPCs. 
 
3.3 Results 
3.3.1 Electrophysiological characterization of NPCs, 
neuroblasts and granule cells 
 
Based on their morphological characteristics and their pattern of 
membrane currents, two groups of nestin-immuno-positive cells could be 
distinguished [20]. The EGFP-positive cells were considered to be non-neuronal 
because of their failure to spike in response to depolarizing current injection. 
Type 1 cells exhibited passive membrane properties with nearly linear current-
voltage characteristics. Type 2 cells were outwardly rectifying, they had lower 
Vm and Cm values and higher Rm and Ra values (Type 1: Vm= -79.6 ± 0.1 mV; 
Cm= 16.4 ± 0.7 pF; Rm= 82.3 ± 8.2 MΩ; Ra= 24.8 ± 0.7 MΩ; Type 2: Vm= -69.2 ± 
1.6 mV; Cm= 12.7 ± 1.3 pF; Rm= 841.0 ± 130.3 MΩ; Ra= 36.0 ± 2.7 MΩ). 
Because of the small size and fragility of neuroblasts, perforated patch clamp 
technique was used to record membrane currents. Hyperpolarizing current 
pulses elicited large voltage deflections in all neuroblasts, which correspond 
with their outwardly rectifying properties. Immature granule cells had a higher 
Rm and Ra value than mature granule cells and fired only a single action 
potential, whereas mature granule cells had a lower firing threshold (immature 
granule cells: Vm= -65.6 ± 8.0 mV; Cm= 11.7 ± 1.9 pF; Rm= 590.7 ± 48.8 MΩ; 
Ra= 54.9 ± 4.2 MΩ; mature granule cells: Vm= -64.9 ± 2.0 mV; Cm= 12.2 ± 0.9 
pF; Rm=313.80 ± 56.3 MΩ; Ra= 46.7 MΩ).  
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3.3.2 P2X7 receptor-mediated currents in identified NPCs 
 
Because of the special pharmacological fingerprint, we could identify the 
P2X7 receptor on the different types of cells. First, we applied the general P2 
agonist, ATP (1 mM) and the prototypic receptor agonist Dibenzoyl-ATP 
(BzATP (300µM)) in the presence of normal artificial cerebrospinal solution 
(aCSF), and aCSF containing no Mg2+ and low Ca2+ concentration (low X2+). As 
compared with normal aCSF, the current responses greatly increased in low 
X2+. The strong potentiation of the response to ATP in the absence of Mg2+ has 
been already observed in earlier studies and led to the suggestion that not ATP 
itself, but ATP4- is the active ligand at the receptor [120]. For this reason, low 
X2+ medium was used for the further experiments. Increasing concentrations of 
ATP (100-30000 µM) and BzATP (30-3000 µM) were superfused to construct 
concentration-response curves. Based on previous experiments, we did not 
investigate the effects of higher concentrations to avoid possible cell-damage of 
NPCs [116]. Due to the lack of an unequivocal maximal effect, the generated 
Hill plots for ATP (Imax= -1225.9 ± 459.3 pA; EC50= 1009.7 ± 531.0 µM) and 
BzATP (Imax= -1297.5 ± 77.8 pA; EC50= 7423.3 ± 1354.5 µM) are only of limited 
significance. Compared with other P2X receptor subtypes, we found a relatively 
low potency of ATP, however, BzATP appeared to be more potent than the 
endogenous ligand. As expected, the application of BzATP at various holding 
potentials and the resulting I/V curve indicated a reversal potential near 0 mV (-
1.2 ± 6.0 mV, n=6), characteristic for nonselective cationic channels. The 
application of the highly selective antagonist A-438079 at two different 
concentrations (1 µM; 10 µM), gradually decreased the effect of the agonist. All 
in all, the described experiments give a proof of the presence of the P2X7 
receptor. A remaining question to be answered is, whether the receptor is 
located at the SGZ NPCs themselves or at neighboring cells, which release 
non-identified transmitters by the ATP-induced stimulation and have an indirect 
influence on the NPCs under investigation. After determining the BzATP 
induced currents, we prepared excised patches. Application of the same 
concentration of BzATP resulted decreased, but not abolished currents. Another 
observation was, that the BzATP-induced current was not altered in the 
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presence of a cocktail containing antagonists for NMDA receptors (AP-5), non-
NMDA receptors (CNQX), GABAA receptors (gabazine), and a blocker of Na
+-
dependent action potentials (TTX). In view of the stability of the currents 
amplitudes by BzATP in the presence of such a cocktail, and the presence of 
the currents after withdrawing the recording pipette, it can be concluded that 
BzATP acts directly at P2X7 receptors localized at the membrane of NPCs in 
the SGZ. The same experiments were performed at neuroblasts and granule 
cells. At the case of neuroblast we obtained the same results; BzATP-induced 
currents were detected on the neuroblasts themselves. Eventually, hippocampal 
granule cells (both immature and mature cells) responded to BzATP only with 
very small current amplitudes. The failure of the specific antagonist, A-438079 
to depress the BzATP-induced responses exclude the presence of the receptor 
at granule cells. As a result of these experiments, we can reveal, that during the 
maturational process of SGZ neurogenesis, the expression of the P2X7 
receptor is lost.  
 
3.3.3 P2Y receptor-mediated currents in identified NPCs 
 
NPCs were described to possess not only P2X7, but also P2Y1;2;4 
receptors [121]. To prove the presence of functional P2Y receptors we applied a 
series of receptor antagonists, ADP-β-S (P2Y1;12;13), UDP (P2Y6), and UTP 
(P2Y2;4) at a holding potential of -30 mV to unmask outward K+ currents. The 
NPCs responded in all case with outward currents. The response of all three 
nucleotides was abolished after replacing all K-gluconic acid in the pipette 
solution by equimolar CsCl, which prevents the outward flow of K+. Decreasing 
EGTA concentration in the pipette solution did not alter the nucleotide-induced 
currents, therefore we could exclude the involvement of Ca2+-dependent 
potassium channels. The highly selective antagonist MRS2179 inhibited the 
effects of ADP-β-S and UDP. In addition, the selective P2Y6 receptor 
antagonist MRS2578 strongly depressed the UDP effects. 
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3.3.4 P2X7- and P2Y1 receptor immunoreactivities 
 
Confocal laser scanning microscope was used to evaluate 
immunohistochemical images. We prepared hippocampal slices from 
Tg(nestin/EGFP) mice, stained for P2X7/P2Y1 receptors. We found co-
localization of the receptor-IR with nestin-EGFP and GFAP not just in the SGZ, 
but also in ectopic cells.  
 
3.4 Discussion 
 
Earlier investigations indicate the presence of P2X7 and P2Y1 receptors 
at embryonic and adult proliferating NPCs [122]. P2X7 receptors have been 
reported to stimulate neuronal differentiation in cultured NPCs [123]. The 
noxious influence of the preparation procedures and the presence of high 
concentrations of growth factors may change the properties of these cells. 
Therefore, we used brain slices to make experiments on cells in a  more natural 
environment, where the local neuronal networks are kept in-tact [124].  In our 
work, we identified P2X7 and P2Y1 receptors on cells during the different 
stages of postnatal neurogenesis. A whole range of data strongly suggest that 
the BzATP and ATP currents recorded by us are due to the activation of P2X7 
receptors. 1) The special agonist BzATP was more potent than ATP itself [125]. 
2) The use of low X2+ solution strongly potentiated the effects of the agonists 
[120]. 3) The BzATP-induced current reversed its polarity near 0 mV, due to the 
opening of cationic P2X receptor channels. 4) The selective antagonist A-
438079 concentration-dependently decreased the BzATP current [126]. 
Eventually, the question arises, whether the stimulation of astroglial P2X7 
receptors leads to the release of a signaling molecule that might modulate 
NPCs and neuroblasts indirectly. We carried out various experiments and 
observed a direct effect of BzATP on the investigated cells. First, after 
establishing the whole-cell configuration and recording BzATP induced currents, 
we prepared excised patches, where the cells were no longer in physical 
contact with the surrounding tissue. A smaller current amplitude was still 
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recordable. Second, a mixture of antagonists for NMDA, AMPA, and GABAA, 
receptors (AP-5, CNQX, and gabazine) as well as the voltage–sensitive Na2+ 
channels (TTX) were co-applied with BzATP, which failed to decrease the effect 
of BzATP. Due to the major role of extracellular purines and pyrimidines during 
embryogenesis and postnatal development [127], the described experiments 
were also carried out on neuroblasts and granule cells. Our results suggest that 
neuroblasts possess P2X7 receptors themselves. In contrast, granule cells are 
devoid of the receptor, in agreement with the suggestion, that the expression of 
P2X7 receptor is lost during the maturation process [128].  
P2Y1 receptors have been reported to promote proliferation [129] and 
neuroblast migration [130]. We also performed patch clamp recordings to prove 
the presence of functional P2Y receptors on NPCs. We applied a series of P2Y 
agonists (ADP--S, UDP, UTP), and found that, outward currents could be 
recorded in all cases near the equilibrium potential of P2X7 receptor currents. 
The selective P2Y1 receptor antagonist, MRS2179 inhibited the ADP--S- and 
UDP-induced currents. In the case of UDP the P2Y6 receptor antagonist 
MRS2578 also had an inhibiting effect, indicating a possible release of 
ATP/ADP from surrounding astrocytes/NPCs. This ATP/ADP is then assumed 
to activate an outward K+ current of NPCs via P2Y1 receptor stimulation [131].  
 
 
3.5 Conclusion  
 
The effect of an epileptic seizure on the expression of P2X7 receptor has 
been widely investigated [132] [133]. Further experiments of our working group 
showed an increase of P2X7 and P2Y1 receptor sensitivity after pilocarpine- or 
kainic acid-induced seizures. We hypothesize that status epilepticus (SE) 
causes a metabolic constraint to NPCs which in turn leads to a massive outflow 
of nucleotides into the neuronal environment. The stimulation of the overactive 
P2Y1 receptor leads to increased proliferation and migration of NPCs to ectopic 
sites. Although, on the one hand the blockade of P2X7 receptors protects hilar 
neurons against the injurious effect of SE, on the other hand, it supports the 
survival, ectopic migration and neuronal differentiation of NPCs as well as their 
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integration into pathological neuronal circuits. Therefore, the stimulation of the 
overactive P2X7 receptor counterbalances this effect, resulting in 
apoptosis/necrosis of surplus NPCs, and prevention of the chronic 
manifestation of epilepsy. 
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5 Appendices 
 
Abbreviations 
 
ATP – adenosine-triphosphate 
A-438079 - 3-[[5-(2,3-Dichlorophenyl)-1H-tetrazol-1-yl]methyl]pyridine 
aCSF – artificial cerebrospinal fluid 
ADP- -S - Adenosine-5′-0-(2-thiodiphosphate) 
AMPA - α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
AP-5 - (2R)-amino-5-phosphonovaleric acid 
BrdU - 5-bromo-2'-deoxyuridine 
BzATP -  2'(3')-O-(4-Benzoylbenzoyl)adenosine-5'-triphosphate 
CA1;2;3 – cornu ammonis1; 2; 3 
Cm – cell membrane capacitance 
CNQX - 6-cyano-7-nitroquinoxaline-2,3-dione 
CNS - central nervous system 
CsCl – cesium chloride 
DCX – doublecortin 
DG – dentate gyrus 
EC – enterohinal cortex 
EC50 – half maximal effective concentration 
EGFP – green fluorescent protein 
EGTA - ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid 
GABA – - aminobutyric acid 
GFAP – glial fibrillary acidic protein 
Imax – maximal current 
KA – kainic acid 
MF – mossy fiber 
MRS2179 -  2'-Deoxy-N6-methyladenosine 3',5'-bisphosphate 
MRS2578 - N,N''-1,4-Butanediylbis[N'-(3-isothiocyanatophenyl)thiourea 
NeuN -  Hexaribonucleotide Binding Protein-3 
NMDA - N-Methyl-D-aspartic acid 
NPC – neural progenitor cell 
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OB – olfactory bulb 
PG – periglomerular cell 
PP – perforant path 
Prox1 – prospero homeobox protein-1 
PSA-NCAM - polysialylated-neural cell adhesion molecule 
Ra – access resistance 
Rm – input resistance 
RMS – rostral migratory stream 
SC – Schaefer Collateral 
SE – status epilecticus 
SGZ – subgranular zone 
Sox2 - SRY (sex determining region Y)-box 2 
SVZ – subventricular zone 
TTX – tetrodotoxin 
UDP – uridine diphosphate 
UTP – uridine triphosphate 
Vm – membrane potential 
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